| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Studies |
-Hydroxylase Gene in 17
-Hydroxylase Deficiency
Third Department of Internal Medicine, Miyazaki Medical College (H.Y., M.N., M.M., S.M.), Kiyotake, Miyazaki 88916; and the National Cardiovascular Center Research Institute (M.M., K.K.), Suita, Osaka 565, Japan
Address all correspondence and requests for reprints to: Masamitsu Nakazato, M.D., Ph.D., Third Department of Internal Medicine, Miyazaki Medical College, 5200 Kihara, Kiyotake, Miyazaki 88916, Japan. E-mail: nakazato{at}post.miyazaki-med.ac.jp
17
-Hydroxylase deficiency (17OHD) is an autosomal recessive disorder
that produces an excess of mineralocorticoids and sexual
differentiation abnormalities. Using DNA sequencing analysis of the
17
-hydroxylase (CYP17) gene from a Japanese patient
with 17OHD, we identified a new type of genetic abnormality in this
disease, a G to A transition at position +5 in the splice donor site of
intron 7 of the CYP17 gene. In vitro
expression analysis of an allelic minigene that consists of exons 68
of the patients CYP17 gene showed that the transition
causes the skipping of exon 7. This exon skipping alters the
translational reading frame of exon 8 and introduces a premature stop
codon (TAA) at amino acid position 410 proximal to the heme
iron-binding site essential for the enzymatic activity of
CYP17. Restriction enzyme analysis showed that the
patient is homozygous for the mutated CYP17 gene, and
the parents are heterozygotes. This is the first reported patient with
17OHD caused by the splice site mutation in the CYP17
gene.
This article has been cited by other articles:
![]() |
T. Kubo, S.-R. Kim, K. Sai, Y. Saito, T. Nakajima, K. Matsumoto, H. Saito, K. Shirao, N. Yamamoto, H. Minami, et al. FUNCTIONAL CHARACTERIZATION OF THREE NATURALLY OCCURRING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE CES2 GENE ENCODING CARBOXYLESTERASE 2 (HCE-2) Drug Metab. Dispos., October 1, 2005; 33(10): 1482 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costa-Santos, C. E. Kater, E. P. Dias, and R. J. Auchus Two Intronic Mutations Cause 17-Hydroxylase Deficiency by Disrupting Splice Acceptor Sites: Direct Demonstration of Aberrant Splicing and Absent Enzyme Activity by Expression of the Entire CYP17 Gene in HEK-293 Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 43 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Martin, C. J. Lin, E. M. F. Costa, M. L. de Oliveira, A. Carrilho, H. Villar, C. A. Longui, and B. B. Mendonca P450c17 Deficiency in Brazilian Patients: Biochemical Diagnosis through Progesterone Levels Confirmed by CYP17 Genotyping J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5739 - 5746. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Di Cerbo, A. Biason-Lauber, M. Savino, M. R. Piemontese, A. Di Giorgio, M. Perona, and A. Savoia Combined 17{alpha}-Hydroxylase/17,20-Lyase Deficiency Caused by Phe93Cys Mutation in the CYP17 Gene J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 898 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biason-Lauber, B. Kempken, E. Werder, M. G. Forest, S. Einaudi, M. B. Ranke, N. Matsuo, V. Brunelli, E. J. Schönle, and M. Zachmann 17{alpha}-Hydroxylase/17,20-Lyase Deficiency as a Model to Study Enzymatic Activity Regulation: Role of Phosphorylation J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1226 - 1231. [Abstract] [Full Text] |
||||
![]() |
Y. Suzuki, T. Nagashima, Y. Nomura, K. Onigata, K. Nagashima, and A. Morikawa A New Compound Heterozygous Mutation (W17X, 436+5G->T) in the Cytochrome P450c17 Gene Causes 17{alpha}-Hydroxylase/17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 199 - 202. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |